McLoughlin Margaret
- SEC CIK
- 0001770823
No open-market purchases or sales filed in the past year.
Current role at each company
- QNCX Quince Therapeutics, Inc.Directoras of Jan 21, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McLoughlin Margaret as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 (view filing) | Aug 8 | 1 day | McLoughlin MargaretDirector | PPurchase | +8.00K | $1.23 | +$9.84K | New position8.00K after | |
| Oct 12, 2021 (view filing) | Oct 8 | 4 days | McLoughlin MargaretDirector | SSale | −1.00K | $88.93 | −$88.9K | −100.0%0 after | |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | McLoughlin MargaretDirector | SSale | −6.00K | $95.44 | −$572.6K | −100.0%0 after | 5 lots |